Introduction
Nearly 50% of human immunodeficiency virus (HIV)-positive individuals in the US are now aged 50 or older (Vance, McGuinness, Musgrove, Orel, & Fazeli, 2011) . Both older age and HIV increase the risk of cognitive dysfunction, though it is unclear whether or not the two interact (Ances, Ortega, Vaida, Heaps, & Paul, 2012; Becker, Lopez, Dew, & Aizenstein, 2004; Bhatia, Ryscavage, & Taiwo, 2011; Iudicello, Paul Woods, Deutsch, Grant, & Group, 2012; Manly et al., 2011; Morgan et al., 2012) . Additionally, older age is associated with higher risk of depression and anxiety (Kohler, Thomas, Barnett, & O'Brien, 2010) , which can further worsen cognition (Alexopoulos, Kiosses, Klimstra, Kalayam, & Bruce, 2002; Lockwood, Alexopoulos, & van Gorp, 2002; Wang et al., 2008) . Identifying markers of cognitive vulnerability would allow intervention before symptoms significantly affect daily life.
Subjective memory complaints (SMCs) may have particular clinical value in adults undergoing pathological aging processes. SMCs were shown to correlate with informants' memory rating in adults diagnosed with mild cognitive impairment (MCI) or dementia (Abner, Kryscio, Caban-Holt, & Schmitt, 2015; Buckley et al., 2015; Salem, Vogel, Ebstrup, Linneberg, & Waldemar, 2015) , and to correlate with subjective mood (Yates, Clare, Woods, & Matthews, 2015) . SMCs have also been associated with poorer verbal episodic memory performance (Gifford et al., 2015) . However, previous studies in HIV have found stronger association between SMCs and mood (Au et al., 2008; van Gorp et al., 1991) rather than with cognitive performance.
We examined if SMC ratings correlated with objective memory performance in HIV-positive and HIV-negative adults. We hypothesized that SMC ratings would correlate with objective impairments more significantly in HIV-positive adults than controls.
Methods

Participants
We enrolled 35 HIV-positive and 21 HIV-negative adults (n = 56). Groups were similar with respect to race, sex, age, and education (Table 1 ). Participants endorsing current substance abuse (alcohol, cocaine, opiates) or HIV-positive participants not on antiretroviral therapy (ART) were excluded. Participants gave informed consent, approved by the Vanderbilt Institutional Review Board and Human Research Protection Program.
Memory and mood measures
The Memory Functioning Questionnaire (MFQ) is a 64-item subjective survey of current memory problems, rated from 1 to 7 (Gilewski & Zelinski, 1988) . The Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) are 21-item self-report questionnaires, measuring incidence and severity of current depressive/ anxiety symptoms, rated from 0 to 3 (Beck, Epstein, Brown, & Steer, 1988; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) . For the MFQ, BDI, and BAI, participants answered regarding the previous 30 days, including their study day.
Cognitive tasks
Tasks were chosen for reliability in accurately assessing episodic and working memory, executive functioning, and attention. The Selective Reminding Task (SRT) measures episodic verbal memory (Buschke, 1973) . Participants are read a list of 16 words and asked to recall as many as possible. Participants completed eight immediate recall trials. Before each trial, experimenter re-reads only the words that the participant failed to recall. Recall and Recall Consistency (words recalled in 2 sequential trials without reinforcement) were recorded. Participants completed a Delayed Recall trial after approximately 25 minutes.
Participants completed four CogState tasks (Fredrickson et al., 2010) previously used in HIV-positive adults (Boivin et al., 2010; Cysique, Maruff, Darby, & Brew, 2006; Thiyagarajan et al., 2010; Winston et al., 2012) : Groton Maze (executive functioning), Detection (psychomotor functioning), Identification (visual attention), and One-Card Learning (OCL) (working memory).
Data analysis
Group means were calculated for age, BDI/ BAI Scores, MFQ Score, and cognitive performance measures, and compared using independent samples t-tests. In the HIV-positive group, mean CD4+ T-cell nadir and current CD4+ counts were obtained from medical records (Ellis et al., 2011) . For the SRT, Total Recall and Recall Consistency were calculated for the full eight-trial task (SRT-T), as well as for the first four (SRT-F) and last four (SRT-L) trials.
"Accuracy" on the CogState tasks was defined as an arcsine transformation of the proportion of correct to incorrect responses. Pearson Correlations (2-tailed) were calculated between MFQ score, age, BDI/BAI score, SRT-T, SRT-F, and SRT-L performance measures, CogState accuracy measures; and in the HIV-positive group, CD4+ nadir. Multiple regression analysis was conducted to evaluate the relationship of MFQ and BDI scores to Total Recall on the SRT-T.
Results
Group means and standard deviations for the descriptive, behavioral, and cognitive data can be found in Table 1 . There were no significant group differences in age or education. Mean BDI, BAI, and MFQ scores were not significantly different between groups.
HIV-negative participants had significantly higher Total Recall on the SRT-T compared to HIV-positive participants (t = 4.270, p < .001), while SRT-T Recall Consistency was not significantly different between groups. HIV-negative participants also showed significantly higher Delayed Recall compared to HIV-positive participants (t = 3.330, p = .002).
When SRT immediate performance was split between the first four (SRT-F) and last four (SRT-L) trials, Recall and Recall Consistency were significantly different between groups on the first four (SRT-F Recall t = 4.026, p < .001; SRT-F Consistency t = −4.21, p < .001) and last four (SRT-L Recall t = 4.218, p < .001; SRT-L Consistency t = 4.275, p < .001) trials, shown in Figure 1 . Paired t-tests revealed that differences in Recall Consistency between SRT-F and SRT-L were significantly There were no significant correlations between mood ratings or MFQ and age, in either group. Age was significantly correlated with SRT-T Recall and Delayed Recall in the HIV-negative group (age × SRT-T corr = −0.492, p = .024; age × SRT-T Delay corr = −0.546, p = .010), but not the HIV-positive group. There were no sex differences in MFQ scores in either group, or correlations between current or nadir CD4+ count and any cognitive measures. Despite statistically insignificant differences in BDI score between groups, regression analysis showed that in a model including MFQ and BDI scores, BDI explained a significant portion of performance variance on the SRT-T Recall in the HIV-negative group (F (2,18) = 6.36, Sig = 0.008, BDI beta = −0.516, MFQ beta = 0.180), whereas in the HIV-positive group, MFQ explained a significant portion of variance in SRT-T Recall (F(2,30) = 3.45, Sig = 0.045, BDI beta = 0.23, MFQ beta = 0.446).
Discussion
The HIV-positive participants in this study had significantly lower scores on verbal episodic memory (SRT) and recognition working memory (OCL) tasks compared to HIV-negative participants. Previous studies have linked episodic memory failures in HIV to the loss of fronto-striatal white matter and hippocampal volume (Castelo, Sherman, Courtney, Melrose, & Stern, 2006; Pfefferbaum et al., 2014) , impairing memory storage and retrieval, which may be the underlying mechanisms in this HIV-positive group. On the SRT, differences in Recall Consistency between early and late trials of the task may reflect impairment in transferring encoded information from short-to long-term storage.
Prior studies have shown strong correlations between SMCs and mood ratings (van Gorp et al., 1991) . However in this study, SMC scores accounted for a greater portion of SRT performance variance. This may indicate that in HIV-positive adults, SMCs may be a more salient marker of actual cognitive deficits than in HIV-negatives, and may deserve closer monitoring. A unique property of this sample was similar depression ratings between groups. Because of the higher proportion of mood disorders in HIV-positive adults, it may be more clinically relevant to compare HIV-positive populations to controls with higher mood ratings, to examine the effects of serostatus alone.
Our results support the use of SMCs as a marker to identify memory impairments in adults experiencing pathological aging processes, versus "normal" agerelated cognitive changes. This is an important distinction, since studies of cognitively normal adults have found little to no correlation between SMCs and performance (Abner et al., 2015; Dalla Barba, La Corte, & Dubois, 2015; Fritsch, McClendon, Wallendal, Hyde, & Larsen, 2014; Howieson et al., 2015; Hulur, Hertzog, Pearman, Ram, & Gerstorf, 2014) . Our positive results may also be due to the more thorough SMC measure used versus other common SMC instruments. The MFQ's more detailed query of memory may more accurately portray deficits in memory function.
Our design was insufficient to explore biochemical factors of HIV infection and treatment that may affect cognition and mood. Relative CNS penetrance of different ARTs (Decloedt, Rosenkranz, Maartens, & Joska, 2015; Skinner, Adewale, DeBlock, Gill, & Power, 2009 ), ART neurotoxicity (Akay et al., 2014; Underwood, Robertson, & Winston, 2015) , mood disorders (Dal-Bo et al., 2015; Silveira et al., 2012) , substance abuse history (Byrd et al., 2011) and length and severity of HIV infection (Heaton et al., 2015) can all negatively affect cognitive performance in aging HIV-positive adults, and fluctuate over time (Dawes et al., 2008) . Accounting for these differences in disease and treatment are necessary to further specify individual risk factors for cognitive changes.
Conclusions
This study showed that memory performance was significantly different between HIV-negative and HIVpositive adults, and that in HIV-positive adults, SMCs correlated with episodic and working memory performance. Differences in SMCs and memory performance were not explained solely by depressive symptoms.
These data indicate that measuring SMCs may have clinical value, to monitor cognitive changes in HIV-positive adults. Adding structured SMC measures to routine assessments may help identify those who should be more closely monitored for HAND symptoms, leading to earlier, more effective interventions for adults aging with HIV.
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